Literature DB >> 15668942

Mutations in ZASP define a novel form of muscular dystrophy in humans.

Duygu Selcen1, Andrew G Engel.   

Abstract

Myofibrillar myopathy (MFM) is a morphologically distinct disorder in which disintegration of the Z-disk and then of the myofibrils is followed by abnormal accumulation of multiple proteins. Mutations in desmin, alphaB-crystallin, and myotilin, all Z-disk-related proteins, cause MFM in the minority of cases. ZASP (a Z-band alternatively spliced PDZ motif-containing protein) is another Z-disk-associated protein, and targeted deletion of ZASP in mouse causes skeletal and cardiac myopathy. We therefore searched for mutations in ZASP in 54 MFM patients and detected 3 heterozygous missense mutations in 11. Their age at onset was 44 to 73 years. Dominant inheritance was apparent in seven patients, cardiac involvement in three, and signs of peripheral neuropathy in five. Most patients had proximal and distal weakness, but in six, the weakness was greater distally than proximally. Ten carried either of two mutations in exon 6 (A147T and A165V) at or within a motif important in linking ZASP to the Z-disk; one carried a missense mutation in exon 9 (R268C). We conclude that (1) mutations in ZASP cause stereotyped MFM pathology; (2) cardiomyopathy, distal more than proximal weakness, and neuropathy are in the spectrum of zaspopathy; and (3) mutations in ZASP define a novel form of autosomal dominant muscular dystrophy in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668942     DOI: 10.1002/ana.20376

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  76 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish.

Authors:  Mirko Völkers; Nima Dolatabadi; Natalie Gude; Patrick Most; Mark A Sussman; David Hassel
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

Review 3.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

Review 4.  The sarcomeric Z-disc: a nodal point in signalling and disease.

Authors:  Derk Frank; Christian Kuhn; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

5.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

6.  Cypher/ZASP is a novel A-kinase anchoring protein.

Authors:  Changsong Lin; Xiaogang Guo; Stephan Lange; Jie Liu; Kunfu Ouyang; Xiang Yin; Liujun Jiang; Yibo Cai; Yongxin Mu; Farah Sheikh; Sheng Ye; Ju Chen; Yuehai Ke; Hongqiang Cheng
Journal:  J Biol Chem       Date:  2013-08-31       Impact factor: 5.157

7.  Flexible expressed region analysis for RNA-seq with derfinder.

Authors:  Leonardo Collado-Torres; Abhinav Nellore; Alyssa C Frazee; Christopher Wilks; Michael I Love; Ben Langmead; Rafael A Irizarry; Jeffrey T Leek; Andrew E Jaffe
Journal:  Nucleic Acids Res       Date:  2016-09-29       Impact factor: 16.971

8.  Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

Authors:  Marta Barrachina; Jesús Moreno; Salvador Juvés; Dolores Moreno; Montse Olivé; Isidre Ferrer
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 10.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.